NCT06309459View on ClinicalTrials.gov

Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

May 1, 2023

Study Completion Date

May 1, 2023

Conditions
Triple Negative Breast CancerCarbonic Anhydrase IX
Interventions
DIAGNOSTIC_TEST

Carbonic anhydrase staining levels

CA IX is a transmembrane protein, it exhibits cytoplasmic membrane staining. Immunohistochemically positive cells were graded as Low staining if they constituted \<10% of the total and high staining if they constituted ≥ 10% (15).

Trial Locations (1)

46000

Kahramanmaraş Sütçü İmam University, Kahramanmaraş

All Listed Sponsors
lead

Kahramanmaras Sutcu Imam University

OTHER

NCT06309459 - Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma | Biotech Hunter | Biotech Hunter